|
GAS2L3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
4.09779998822302E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.7998935675223E-12 |
| Stage1-vs-Stage2 |
1.768180E-01 |
| Stage1-vs-Stage3 |
1.154390E-01 |
| Stage1-vs-Stage4 |
3.802100E-03 |
| Stage2-vs-Stage3 |
7.769800E-01 |
| Stage2-vs-Stage4 |
4.638400E-01 |
| Stage3-vs-Stage4 |
2.229800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.90669999958304E-07 |
| Normal-vs-Asian |
3.756300E-03 |
| Caucasian-vs-AfricanAmerican |
2.020000E-04 |
| Caucasian-vs-Asian |
6.712600E-01 |
| AfricanAmerican-vs-Asian |
4.314400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
8.750300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.59489999999841E-05 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
8.17590000000701E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.548780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.565800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.852610E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.128200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.535200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.134200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.984440E-04 |
| Normal-vs-Grade 2 |
1.62447832963153E-12 |
| Normal-vs-Grade 3 |
<1E-12 |
| Normal-vs-Grade 4 |
2.8408997376772E-10 |
| Grade 1-vs-Grade 2 |
5.154600E-01 |
| Grade 1-vs-Grade 3 |
3.569000E-01 |
| Grade 1-vs-Grade 4 |
3.401800E-03 |
| Grade 2-vs-Grade 3 |
4.017200E-01 |
| Grade 2-vs-Grade 4 |
1.78537999999673E-05 |
| Grade 3-vs-Grade 4 |
5.185700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
1.62436730732907E-12 |
| ccA subtype-vs-ccB subtype |
7.04025726605551E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.416600E-03 |
| N0-vs-N1 |
3.158100E-02 |
|
|
